These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


108 related items for PubMed ID: 3775386

  • 1. Postclotting fates of thrombin.
    Seegers WH.
    Semin Thromb Hemost; 1986 Jul; 12(3):181-3. PubMed ID: 3775386
    [Abstract] [Full Text] [Related]

  • 2. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B, Griffin JH.
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [Abstract] [Full Text] [Related]

  • 3. The anticoagulant properties of mast cell product, chondroitin sulphate E.
    Scully MF, Ellis V, Seno N, Kakkar VV.
    Biochem Biophys Res Commun; 1986 May 29; 137(1):15-22. PubMed ID: 3087353
    [Abstract] [Full Text] [Related]

  • 4. The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors.
    Thompson EA, Salem HH.
    Thromb Haemost; 1987 Oct 28; 58(3):806-10. PubMed ID: 2829375
    [Abstract] [Full Text] [Related]

  • 5. HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.
    Kretz CA, Cuddy KK, Stafford AR, Fredenburgh JC, Roberts R, Weitz JI.
    Thromb Haemost; 2010 Jan 28; 103(1):83-93. PubMed ID: 20062917
    [Abstract] [Full Text] [Related]

  • 6. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T, Straub PW, Haeberli A.
    Thromb Haemost; 1994 Jan 28; 71(1):49-53. PubMed ID: 8165646
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082.
    Ofosu FA, Fareed J, Smith LM, Anvari N, Hoppensteadt D, Blajchman MA.
    Eur J Biochem; 1992 Jan 15; 203(1-2):121-5. PubMed ID: 1730217
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J, von Pape KW, Blaurock M.
    Thromb Haemost; 1994 Mar 15; 71(3):280-3. PubMed ID: 8029789
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L, Dewar L, Song Y, Kulczycky M, Blajchman MA, Fenton JW, Andrew M, Delorme M, Ginsberg J, Preissner KT.
    Thromb Haemost; 1995 Mar 15; 73(3):405-12. PubMed ID: 7545318
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of heparin cofactor II on the antithrombin III activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women].
    Akai Y, Shiga S, Tohyama K, Shimatsu A, Ichiyama S.
    Rinsho Byori; 2000 Sep 15; 48(9):867-71. PubMed ID: 11051806
    [Abstract] [Full Text] [Related]

  • 19. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD.
    Fed Proc; 1985 Feb 15; 44(2):404-9. PubMed ID: 3155697
    [Abstract] [Full Text] [Related]

  • 20. Tissue thromboplastin induced reversible DIC and heparin-enhanced inhibitors in dogs.
    Marbet GA, Griffith MJ.
    Thromb Haemost; 1986 Feb 28; 55(1):78-85. PubMed ID: 3518133
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.